is bydureon a glp-1 GLP-1R agonists approved by the
Description
Telehealths Exponential Growth Beyond convenience, telehealth is reshaping access
for postoperative morbidity was used (grade IV)
They carry no risk of physical dependence or abuse
(Top holdings, as of January 16, 2025, below): Source: Amplify ETFs The Roundhill GLP-1 & Weight Loss ETF (OZEM) is another ETF in this segment, also launched in May 2024
